MoonLake Immunotherapeutics
MoonLake Immunotherapeutics Logo
About MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company focused on developing innovative therapies for inflammatory diseases. Its lead product, Sonelokimab, is a novel investigational Nanobody targeting conditions such as hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, and psoriasis. The company aims to elevate patient outcomes by addressing major unmet medical needs in inflammation. Headquartered in Zug, Switzerland, MoonLake Immunotherapeutics serves patients worldwide.
Address
Dorfstrasse 29,
Zug, 6300
Switzerland
Year founded
2020
Number of employees
100-200
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
